Seminars in Oncology
Volume 33, Supplement 12 , Pages 25-26, December 2006

Concluding Remarks: Optimal Treatment for Women With Ovarian Cancer

  • Edward L. Trimble

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Edward L. Trimble, MD, MPH, National Cancer Institute, 6130 Executive Blvd, Suite 7025, Bethesda, MD 20892-7436.

National Cancer Institute, Bethesda, MD.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This activity is supported by an unrestricted educational grant from MedImmune Oncology, Inc., a subsidiary of MedImmune, Inc.

PII: S0093-7754(06)00426-X

doi:10.1053/j.seminoncol.2006.11.004

Seminars in Oncology
Volume 33, Supplement 12 , Pages 25-26, December 2006

Article Tools